KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Dynavax Technologies (DVAX) Accounts Payables (2016 - 2025)

Historic Accounts Payables for Dynavax Technologies (DVAX) over the last 16 years, with Q3 2025 value amounting to $3.9 million.

  • Dynavax Technologies' Accounts Payables fell 4430.81% to $3.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.9 million, marking a year-over-year decrease of 4430.81%. This contributed to the annual value of $9.1 million for FY2024, which is 7275.5% up from last year.
  • Per Dynavax Technologies' latest filing, its Accounts Payables stood at $3.9 million for Q3 2025, which was down 4430.81% from $2.7 million recorded in Q2 2025.
  • Dynavax Technologies' 5-year Accounts Payables high stood at $20.2 million for Q1 2022, and its period low was $2.4 million during Q1 2024.
  • Its 5-year average for Accounts Payables is $5.6 million, with a median of $3.9 million in 2025.
  • As far as peak fluctuations go, Dynavax Technologies' Accounts Payables skyrocketed by 54026.63% in 2022, and later crashed by 6668.04% in 2024.
  • Dynavax Technologies' Accounts Payables (Quarter) stood at $2.6 million in 2021, then grew by 23.5% to $3.2 million in 2022, then surged by 63.34% to $5.2 million in 2023, then skyrocketed by 72.76% to $9.1 million in 2024, then crashed by 56.43% to $3.9 million in 2025.
  • Its last three reported values are $3.9 million in Q3 2025, $2.7 million for Q2 2025, and $4.3 million during Q1 2025.